Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$968K Buy
2,750
+1
+0% +$356 0.34% 63
2025
Q4
$900K Buy
2,749
+135
+5% +$42.8K 0.28% 63
2025
Q3
$738K Buy
2,614
+1
+0% +$290 0.24% 77
2025
Q2
$729K Buy
2,613
+1
+0% +$283 0.27% 72
2025
Q1
$814K Sell
2,612
-107
-4% -$31.6K 0.34% 62
2024
Q4
$709K Buy
2,719
+9
+0.3% +$2.67K 0.25% 76
2024
Q3
$873K Buy
2,710
+1
+0% +$327 0.31% 67
2024
Q2
$846K Buy
2,709
+1
+0% +$294 0.31% 68
2024
Q1
$770K Hold
2,708
0.28% 75
2023
Q4
$780K Buy
2,708
+1
+0% +$272 0.29% 76
2023
Q3
$727K Buy
2,707
+1
+0% +$250 0.36% 66
2023
Q2
$601K Sell
2,706
-74
-3% -$17.2K 0.26% 83
2023
Q1
$672K Buy
2,780
+1
+0% +$245 0.34% 70
2022
Q4
$730K Sell
2,779
-199
-7% -$53.3K 0.42% 57
2022
Q3
$671K Buy
2,978
+1
+0% +$242 0.41% 61
2022
Q2
$724K Buy
2,977
+1
+0% +$245 0.44% 57
2022
Q1
$720K Sell
2,976
-150
-5% -$34.5K 0.34% 66
2021
Q4
$703K Buy
+3,126
New +$660K 0.29% 70

Other funds holding AMGN

Wealth Effects's AMGN Position: Q1 2026 in Review

Wealth Effects increased its Amgen (AMGN) stake by 0.04% in Q1 2026, buying an estimated $356 and bringing the position to 2,750 shares worth $968K. The position accounts for 0.34% of the portfolio, ranked #63.

Wealth Effects first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Wealth Effects held 2,750 shares of Amgen worth $968K as of Q1 2026.
  • Wealth Effects bought 1 Amgen share in Q1 2026, an estimated $356.
  • Amgen made up 0.34% of Wealth Effects's portfolio in Q1 2026, its #63 holding.
  • Wealth Effects first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Wealth Effects's 13F filing for Q1 2026, filed 21 Apr 2026.